Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![StockCompil Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1693635995265110016.png) Stock Analysis Compilation [@StockCompil](/creator/twitter/StockCompil) on x 7813 followers
Created: 2024-10-07 15:58:00 UTC

Artisan Partners on Argenx $ARGX US

Thesis: Argenx’s Vyvgart presents a significant growth opportunity, with blockbuster potential in multiple autoimmune conditions, making it a biotech leader to watch.

(Extract from their Q2 letter)

![](https://pbs.twimg.com/media/GYzLdMgXIAA6lR-.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1843319876066160701/c:line.svg)

**Related Topics**
[$argx](/topic/$argx)

[Post Link](https://x.com/StockCompil/status/1843319876066160701)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

StockCompil Avatar Stock Analysis Compilation @StockCompil on x 7813 followers Created: 2024-10-07 15:58:00 UTC

Artisan Partners on Argenx $ARGX US

Thesis: Argenx’s Vyvgart presents a significant growth opportunity, with blockbuster potential in multiple autoimmune conditions, making it a biotech leader to watch.

(Extract from their Q2 letter)

XXXXX engagements

Engagements Line Chart

Related Topics $argx

Post Link

post/tweet::1843319876066160701
/post/tweet::1843319876066160701